#earnings

Posts mentioning hashtag #earnings

Below are all the posts — topics as well as replies — that mention the hashtag #earnings.

Mention #earnings in your post to continue the discussion!

Interesting twist of an analysis - One Year After the Worst Day: What Fiserv’s Earnings Told Bankers

Pulled from the bottom of this article: https://www.ccgcatalyst.com/thought-leadership/commentary/one-year-after-the-worst-day-what-fiservs-earnings-told-bankers/
Funny how they ignore employee attrition/layoffs for improvement and only concentrate on customer attrition in the analysis. Hmmm.

Our View: What Comes Next for Fiserv
Fiserv is no longer a vendor in freefall, but it is not yet a vendor in recovery. The quarter showed stabilization – guidance held, attrition improving, investment visible – and the strategy is finally coherent: fewer cores, common components, a smaller portfolio. What it has not shown is proof. For institutions on Premier, Precision, or Cleartouch, the direction now points toward CoreAdvance, and CoreAdvance itself is still being built in phases; negotiate which phases you are entitled to, and on what dates, in your next contract, while Fiserv needs retention wins. For DNA institutions, the call placed DNA among Fiserv’s leading client wins, but it still sits outside the CoreAdvance consolidation – get the investment commitment in writing. For banks evaluating Fiserv, this is a buyer’s market: a vendor rebuilding its sales motion will trade price, terms, and conversion support for a reference. Our test for the next 12 to 18 months: named CoreAdvance clients live on phases beyond infrastructure consolidation, attrition improvement appearing in reported banking revenue by late 2027, and divestitures that leave the bank-facing business intact.

My final comment: a year after the worst day, the most useful thing the crash taught the industry has nothing to do with Fiserv in particular. Every critical vendor – public, private equity-owned, or cooperative – has a financial condition, a strategy under revision, and an owner with options. The banks that handled last October calmly were not the ones with the best stock forecasts; they were the ones that already knew which risks they were carrying, had the contract language to match, and could answer their boards from their own files. Yesterday’s call was the best one Fiserv’s bank clients have heard in two years – attrition peaking, guidance held, investment visible, a named, $20 billion CoreAdvance go-live. Put it in the file next to the five questions, and ask the sixth one in writing: the call promised that common componentry will end the question of how many cores Fiserv has – so which componentry, on what dates, reaches the core your institution runs?

CCG Catalyst advises banks, credit unions, and fintech companies on core evaluation, vendor selection, and contract negotiation. If your institution is approaching a core decision, reach out to our team at www.ccgcatalyst.com.

See our latest announcement: CCG Catalyst’s Paul Schaus Named a 2026 Top Consultant by Consulting Magazine

By: Paul Schaus | Founder & Managing Partner, CCG Catalyst Consulting


Lmao they didn't even show how separate products did YoY

Holy moly how bad are things really. They've always showed how separate product buckets did YoY. They completely skipped that this time. Dude was literally fumbling his words trying to justify how bad financially things are WHILE READING OFF A CRUMBLED PIECE OF PAPER JUST SO HE DOESNT HAVE TO SHOW THE NUMBERS. How shameless and brain dead are these people really. Manipulate the numbers, have nothing to show for it and then just dont show anything. Fire everyone in the ELT right now, this company is a dumpsterfire.


This leadership team is doing the job

This board's default setting is to treat SM, SA, and the rest of the ELT like a punchline. I'm not joining that chorus.

I think well of this leadership team because of what they actually reported and decided, not because I claim to know their motives. Non-GAAP EPS came in at $0.70 and beat the Street. Public cloud ARR reached $700 million, up 11%. Adjusted free cash flow was $96 million. They raised the full-year EPS outlook and reaffirmed the ARR and adjusted free cash flow ranges. They've also been putting real investment into AI, including the products and capabilities they just highlighted with the quarter. That's the record. It's why I respect the job they're doing.

On the question this forum never gets tired of asking: my view is that further layoffs are unlikely, but possible; I have no inside information. That is not a forecast I can verify, not a guarantee, and not proof that anyone's job is safe. Earnings don't certify headcount. If there's an official announcement, that will speak for itself. Until then, I'm going to judge the people running the company by the results they put on paper, not by the next date someone invents in a comment.


Scoreboard

Obviously still very early days but there is a part of me that is worried this guy got overvalued more because he looks the part than is

PNC REVENUE: Q1 2024 vs Q3 2026
Metric Q1 2024 Q3 2026 Change
Total revenue $5.15B $6.56B +27%
Net interest income $3.26B $4.21B +29%
Noninterest income $1.88B $2.36B +25%
Diluted EPS (GAAP) $3.10 $4.97 +60%
Adjusted EPS $3.36 $5.09 +51%
Net interest margin 2.57% 2.94% +37

STOCK PERFORMANCE vs S&P
FISV – Lyons exit (post) Jun 15 $47.91 $62.88 +31.2% -2.3% +33.6

TFC – Lyons Day 1 Aug 31 $49.58 $49.38 -0.4% -4.0% +3.6


We Covered the Spread

Finally had time to read the Q3 earnings report after spending 12 hours a day in Walmarts trying to improve first time pick rate and donating what’s left of my lower back to retail.

Beat revenue. Beat EPS. International is rolling, snacks are improving, and Gatorade is doing its part.

Then we lowered the full year outlook because apparently commodities didn’t get the memo.

Basically, we covered the spread in Q3, hammered the under on the rest of the year, and my lower back has entered the transfer portal.


Cigna 3rd quarter! Make that money.

Made billions but can’t even give 5 hrs OT to struggling depts during this peak season due to layoffs.

• Total revenues for the third quarter 2026 increased 6% to $73.7 billion
• Shareholders' net income for the third quarter 2026 was $1.4 billion, or $5.47 per share
• Adjusted income from operations' for the third quarter 2026 was $2.1 billion, or $7.98 per share
• Increasing 2026 outlook for adjusted income from operations' to at least $30.60 per share?
• Hosted 2026 Investor Day, introducing the "Lead to One" vision, setting long-term financial targets, including 10%-14% adjusted EPS CAGR and $50B in cumulative operating cash flow through 2030, and announcing 'Accelerate to One" multi-year $3B modernization and productivity initiative


Q3 is out. The adults in the room delivered.

Non-GAAP EPS came in at $0.70 and beat the Street. Public cloud ARR hit $700M, up 11%. Adjusted free cash flow $96M. Total ARR still climbing. Recurring is 90% of the business. SM and SA reaffirmed the full-year ARR and cash-flow outlook and raised EPS guidance. That’s what happens when leadership actually leads.

A leaner company is a healthier company. Some people left. That’s not a tragedy, it’s how you fund AI and keep the people who produce. If you’re still here, congratulations: you got the easier assignment. Do the work. Raise your output. Stop confusing a performance bar with cruelty.

While half this forum practiced fortune-telling, the ELT steered the company and the results showed up on schedule. Remarkable how often the loudest voices had the least to show for it. Work harder. It’s not complicated, and it never was.


How Ayman legally fibbed - Q1 Results

Products were moved out of core business units and into non core units mid Q. In other words, as q1 progressed and it became clear that core business units were not going to show any growth because of poor performing products, those products were taken out of the core business and relassified as non core. So core businesses did not grow.

The honest cross check is the stuff that can't benefit from the shell game. Total revenue was down 4.0 % year over year and ARR (recurring revenue, subscription and support contracts) was down 3%. License revenue down 8% and professional services down 11%. So all three non cloud pieces fell at once. Cloud grew, but it is still less than half the total.

Bottom line is $1,237M vs $$1,288M a year ago. Open Text continues to shrink despite the multi-million dollar investment in the new GTM model.

Another trick- showing total revenue at negative - 1.7% which is constant currency ex divestiture figures not the actual reported -4.0.


Lumen Technologies posts wider-than-expected Q3 loss per share, revenue miss

Lumen Technologies, Inc. (NASDAQ:LUMN) reported third quarter 2026 results that fell short of analyst expectations, though shares rose 1.3% in after hours trading and after closing 5.89% lower in the regular session.

https://www.investing.com/news/earnings/lumen-technologies-posts-widerthanexpected-q3-loss-per-share-revenue-miss-93CH-5001244


Q3 Earnings

Not looking good for today.We might hit 2010 or older prices. This is abysmal leadership. Stephanie, Kelly, Bob all need to be gone today. Looks like it is the CFO to be the first out. Time to cash out his millions and leave. Interestingly he had the same stock price fall at his last job and FIS fired him. Now we get to hear Stephanie spin it once again and the board will kiss her feet and do nothing. What a joke of a leadership by the board and C suite.


Earnings tommorrow

My guess is higher rev, lower GM. services to product ratio down. AI fluff. This new regime is worse in services than ever. with bad morale. Cloud will be down because the Mission leaders are distracted. These are my predictions based on observation, I have no inside baseball. We will see tomorrow.


is humana's stock expected to rise or fall after the november 6th earnings call ?

Wall Street sentiment heavily suggests high volatility rather than a certain direction, as analysts forecast a steep year-over-year earnings decline. According to options market data compiled by Bloomberg, the market is pricing in an implied stock price move of roughly 8.2% immediately following the November 6, 2026 Q3 earnings release.


Don't Get Overly Excited

There's always the chance of unforeseen obstacles, and temporary enthusiasm especially in managed care, where enthusiasm can blind investors to operational lag and policy risk.

Market reactions usually pull forward years of future expectations in a matter of days. A pull-back on Friday down to around $413 shows the initial euphoric momentum digest as the market separates long-term structural improvement from near-term execution realities.

The Three "Obstacle Zones" Humana Still Has to Navigate

  1. The Multi-Year Revenue Lag (The 2026–2027 Gap)

--The Reality: The 2027 Star Ratings rebound (jumping to 95% of members in 4+ star plans) is a legitimate regulatory win. However, CMS quality bonus payments do not hit Humana’s P&L until 2028.
--The Risk: Humana must bridge late 2026 and all of 2027 on current baseline margins. If medical cost utilization spikes over the next 12 to 18 months, earnings could still face headwinds before the bonus money arrives.

  1. Persistent Utilization & Medical Loss Ratio (MLR) Pressures

--The Reality: Across the senior healthcare industry, outpatient surgeries, hip/knee replacements, and expensive dr-g therapies (like GLP-1s) continue to push medical claims higher.
--The Risk: A high MLR directly eats into operational earnings. Reclaiming Star status gives Humana a massive financial safety net for 2028, but it does not magically lower the cost of caring for members in 2026.

  1. Premium Valuation vs. Historical Averages

--The Reality: After pushing above $430+ (and touching $456.50), HUM’s trailing price-to-earnings (P/E) ratio expanded well beyond its 5-year historical average (~21.5x) toward ~39x.
--The Risk: When a stock trades at a premium valuation based on future earnings expectations, it leaves zero room for operational error. Any minor earnings miss or conservative guidance update in upcoming Q3/Q4 reports can trigger quick 5%–10% profit-taking pullbacks.

How to Frame the Current Setup

While the fundamental floor of the company has undoubtedly been raised (thanks to de-risking the balance sheet via BlackRock and securing future quality bonuses):

--Short-Term (Next 3–6 Months): Expect volatility and digestion. The initial pop was "temporary enthusiasm" pricing in the news. The stock will likely chop between value-support levels ($380–$400) and resistance ($435–$450) as traders weigh high valuation against near-term medical costs.
--Long-Term (2–4 Year Horizon): The core thesis is durable. The Star Ratings recovery prevents a multi-billion dollar revenue cliff in 2028, which is why institutional price targets are sitting much higher ($475 to $590+).

The news fixed the existential tail-risk, but it didn't eliminate the day-to-day work of managing healthcare costs.